Recently, King Charles III of the United Kingdom visited the Melanoma Institute Australia (MIA). The institute’s co-directors, Professor Georgina Long AO and Professor Richard Scolyer AO, along with Associate Professor Linda Martin, discussed with King Charles III the institute’s significant ongoing work in the prevention and understanding of skin cancer. MIA is one of 16 Australian sites involved in the Australian Centre of Excellence in Melanoma Imaging & Diagnosis (ACEMID) initiative – the world’s largest melanoma cohort study. As part of this study, Canfield Scientific’s VECTRA® WB360 whole-body imaging system is utilized to enhance screening examinations and revolutionize research in Australia, which has one of the highest rates of skin cancer globally.